MEC Plus Full List View

By /

MEC Plus

Burkitt Lymphoma
Burkitt Lymphoma
Leidy Isenalumhe, MD
 View PDF
Double Hit Lymphomas
Double Hit Lymphomas
Julio Chavez, MD, MS
 View PDF
CNS Lymphomas
CNS Lymphomas
Sepideh Mokhtari, MD
 View PDF
Current Standard of Therapies in CLL
Current Standard of Therapies in CLL
Javier Pinilla-Ibarz, MD, PhD
 View PDF
New Strategies for MCL
New Strategies for MCL
Bijal Shah, MD, MS
 View PDF
Marginal Zone Lymphomas
Marginal Zone Lymphomas
Sameh Gaballa, MD
 View PDF
Current Status of Cervical Cancer Screening
Current Status of Cervical Cancer Screening
Ritu Salani MD, MBA
 View Video
Role of ADCs in Gynecological Malignancies
Role of ADCs in Gynecological Malignancies
Don S. Dizon, MD, FACP, FASCO
 View Video
Ovarian Cancer: Beyond Carboplatin and Paclitaxel
Ovarian Cancer: Beyond Carboplatin and Paclitaxel
Alexander B. Olawaiye, MD, FRCOG, FACOG, FACS
 View Video
Endocrine Therapy for Advanced Breast Cancer: Current and Future Strategies
Endocrine Therapy for Advanced Breast Cancer: Current and Future Strategies
Reshma L. Mahtani, DO
 View Video
Endocrine Therapy and Targeted Agents for Early-Stage HR+ Breast Cancer
Endocrine Therapy and Targeted Agents for Early-Stage HR+ Breast Cancer
William J. Gradishar, MD, FACP
 View Video
Antibody Drug Conjugates: New Agents and Optimal Sequencing
Antibody Drug Conjugates: New Agents and Optimal Sequencing
Hope S. Rugo, MD, FASCO
 View Video
Immunotherapy for Breast Cancer: Updates and New Directions
Immunotherapy for Breast Cancer: Updates and New Directions
Mark Pegram, MD
 View Video
Prostate Cancer: Role of PSMA PET and Accurately Defining “Neuroendocrine” Prostate
Prostate Cancer: Role of PSMA PET and Accurately Defining “Neuroendocrine” Prostate
Ravi A. Madan, MD
 View Video
Role of Immunotherapy in HNC
Role of Immunotherapy in HNC
Hyunseok (Hyu) Kang, MD, MPH, FACP
 View Video
Renal Cell Carcinoma (RCC): Current Approach to First Line Therapy and Beyond
Renal Cell Carcinoma (RCC): Current Approach to First Line Therapy and Beyond
Petros Grivas, MD, PhD
 View Video
Adjuvant and Neo-adjuvant Therapy for Lung Cancer
Adjuvant and Neo-adjuvant Therapy for Lung Cancer
Janakiraman Subramanian MD, MPH
 View Video
Other Targetable Agents (KRASg 12c, BRafv600, RET and NTRK)
Other Targetable Agents (KRASg 12c, BRafv600, RET and NTRK)
Edgardo S. Santos Castillero, MD, FACP
 View Video
Approach to NSCLC With Targetable Mutations (EGFR, ALK and ROS-1)
Approach to NSCLC With Targetable Mutations (EGFR, ALK and ROS-1)
Jorge J Nieva, M.D.
 View Video
Approach to NSCLC Without Targetable Mutations
Approach to NSCLC Without Targetable Mutations
Luis E. Raez, MD, FACP, FCCP
 View Video
Liquid Biopsy: Advances in the Last Decade and Future Directions
Liquid Biopsy: Advances in the Last Decade and Future Directions
Edgardo S. Santos Castillero, MD, FACP
 View Video
Melanoma as a Paradigm for the Future of Immunotherapy
Melanoma as a Paradigm for the Future of Immunotherapy
Paolo A. Ascierto, MD
 View Video
Novel Immunotherapy Approaches in Hepatobiliary Malignancies
Novel Immunotherapy Approaches in Hepatobiliary Malignancies
Rachna T. Shroff, MD, MS
 View Video
Pancreatic Cancer: Are We Finally Making Progress?
Pancreatic Cancer: Are We Finally Making Progress?
Andrew H. Ko, MD, FASCO
 View Video

Displaying 1,801 - 1,830 of 2,995